Tell Us What You Think

Rate your Quintiles.com experience

Subscribe to Email Based on Your Interests

Set preferences

Information Library

Flexible outsourcing - Get to market faster

To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.

See all

  • Sort by: Most Recent
  • Title
  • Blockbuster reaches 7 new markets in record time

    August 13, 2009
    This study looks at a fully paid up member of ‘Big Pharma’ and its preparation for the international launch of one of its blockbuster drugs. It examines how outsourcing enabled them to get to market in time and then quickly out-perform the competition.

  • Outsourcing for Pan-European launch success

    August 13, 2009
    This study is about research company PharmaMar and the ambitious pan-European launch of their brand Yondelis®. And how, without any sales infrastructure, they were meeting and beating targets faster than anyone thought possible.

  • Poised for success

    June 16, 2009
    Learn how a holistic life cycle approach can improve your commercial organization's productivity and flexibility

  • A Testimonial About Innovex Portugal

    March 30, 2009
    A testimonial about commercialization through Innovex.

  • How to Keep All Your Licenses in Compliance

    March 25, 2009
    Our customer had a series of pharmaceutical and biological products that had been on the market in various countries for 10 years or more. They made a number of manufacturing improvements, and they needed to update their myriad licenses.

  • How to Navigate the New CDISC Standard

    March 25, 2009
    Quintiles – a CDISC Registered Solutions Provider – helps you get every detail right.

  • Maneuvering a Drifting Project Back on Course

    March 25, 2009
    The NDA had been drifting within the FDA for years, and now it was subject to intense scrutiny by two agency reviewers.

  • Jacco Keja, Ph.D.

    March 25, 2009
    Jacco joined Quintiles Consulting in 2007 as Practice Leader, Market Access. Previously, Jacco was responsible for building Organon's global and local competence in Strategic and Operational Pricing, as well as expanding Health Economics and Outcomes Research.

  • John Doyle, Dr. PH

    March 25, 2009
    John was president and a founder of Analytica International a global reimbursement, outcomes and market access consulting firm. He previously led the Oncology and Immunology Economics Research Group at Bristol-Myers Squibb.

  • Adrian McKemey, Ph.D.

    March 25, 2009
    Adrian leads the Product Development and Commercialization consulting practice at Quintiles Global Consulting.